Previous Systemic Treatments
| Patient no. | Diagnosis | No. of lines | Schemes and substances |
| 1 | Colorectal cancer | 1 | FOLFOX/cetuximab |
| 2 | Breast cancer | 5 | FEC, vinorelbine/trastuzumab, capecitabine/trastuzumab, paclitaxel/trastuzumab, capecitabine/lapatinib |
| 3 | Colorectal cancer | 1 | FOLFIRI/bevacizumab |
| 4 | HCC | 0 | |
| 5 | HCC | 0 | |
| 6 | Cholangiocellular carcinoma | 4 | FUFOX, gemcitabine, sorafenib, cetuximab |
| 7 | Colorectal cancer | 3 | FOLFOX, FOLFIRI, FOLFIRI/bevacizumab |
| 8 | HCC | 1 | Sorafenib |
| 9 | Breast cancer | 5 | Paclitaxel/epirubicin, docetaxel/capecitabine, docetaxel/5-fluorouracil, vinorelbine, doxorubicin |
| 10 | Colorectal cancer | 0 | |
| 11 | HCC | 0 | |
| 12 | Breast cancer | 1 | Docetaxel |
| 13 | HCC | 1 | Sorafenib |
| 14 | HCC | 1 | Sorafenib |
| 15 | Colorectal cancer | 1 | FOLFIRI |
| 16 | Breast cancer | 1 | Capecitabine |
| 17 | Breast cancer | 2 | FEC, aromatasin inhibitor |
| 18 | Breast cancer | 4 | FEC, docetaxel, capecitabine, doxorubicin |
| 19 | Breast cancer | 2 | FEC, vinorelbine/capecitabine |
| 20 | HCC | 1 | Sorafenib |
| 21 | HCC | 1 | Sorafenib |
FOLFOX = folinic acid, fluorouracil, oxaliplatin; FEC = fluorouracil, epirubicin, cyclophosphamide; FOLFIRI = folinic acid, fluorouracil, irinotecan; FUFOX = fluorouracil, folinic acid, oxaliplatin.